Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytoreductive Prostatectomy in mHSPC
NCT06350825Phase 3Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Radiographic Progression-Free Survival at 3 years. Started Jan 2016; status: recruiting.
Beyond the preview
Go deeper on NCT06350825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06350825.